Genetical and epigenetical profiling identifies two subgroups of pineal parenchymal tumors of intermediate differentiation (PPTID) with distinct molecular, histological and clinical characteristics

Clinical and molecular heterogeneity of pineal parenchymal tumors: a consensus study

(2021) Anthony P. Y. Liu et al.   ACTA NEUROPATHOLOGICA

Prognosticating survival of pineal parenchymal tumors of intermediate differentiation (PPTID) by grade

(2021) Victor M. Lu et al.   JOURNAL OF NEURO-ONCOLOGY

Recurrent KBTBD4 small in-frame insertions and absence of DROSHA deletion or DICER1 mutation differentiate pineal parenchymal tumor of intermediate differentiation (PPTID) from pineoblastoma

(2019) Julieann C. Lee et al.   ACTA NEUROPATHOLOGICA

Molecular subgrouping of primary pineal parenchymal tumors reveals distinct subtypes correlated with clinical parameters and genetic alterations

(2019) Elke Pfaff et al.   ACTA NEUROPATHOLOGICA

Histopathologic review of pineal parenchymal tumors identifies novel morphologic subtypes and prognostic factors for outcome

(2016) David R. Raleigh et al.   NEURO-ONCOLOGY

Utility of Ki67 immunostaining in the grading of pineal parenchymal tumours: a multicentre study

(2011) M. Fèvre-Montange et al.   NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY